Effects of atorvastatin on hyperlipidemia in kidney disease patients

Japanese Journal of Nephrology

Volumn 49, Issue 1, 2007, Pages 41-48

  Kawamoto, Shinya ^a,b   Kawamura, Tetsuya ^a   Miyazaki, Yoichi ^c   Hosoya, Tatsuo ^c  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Nihonkoukan Hospital   (Japan)

^c NONE

Author keywords

Hyperlipidemia; Lipid nephrotoxicity; Renal function; Statins

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; ATORVASTATIN; CHOLESTEROL; CREATININE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ARTICLE; BLOOD PRESSURE MONITORING; CONTROLLED STUDY; CREATININE CLEARANCE; DRUG EFFECT; HUMAN; HYPERLIPIDEMIA; KIDNEY DISEASE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; UREA NITROGEN BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; ANTICHOLESTEREMIC AGENTS; CARDIOVASCULAR DISEASES; DISEASE PROGRESSION; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEPTANOIC ACIDS; HUMANS; HYPERLIPIDEMIAS; KIDNEY DISEASES; MALE; MIDDLE AGED; PYRROLES; RENAL DIALYSIS;

EID: 33847146720     PISSN: 03852385     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Moorhead JF, Chan MK, El Nahas AM, et al. Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease. Lancet 1982 ; 2 : 1309-1312.
2. Kasiske BL, O'Donnel MP, Garvis WJ, et al. Treatment of hyperlipidemia reduces glomerular injury in obese Zucker rats. Kidney Int 1988 ; 33 : 667-672.
3. Haris PKG, Pukerson ML, Yates J, et al. Lovastatin ameliorates the development of glomerulosclerosis and uremia in experimental nephritic syndrome. Am J Kidney Dis 1990 ; 15 : 16-23.
4. Afzali B, Haydar A, Vinen K, Goldsmith DJA. Beneficial effect of statins on the kidney : the evidence moves from mouse to man. Nephrol Dial Transplant 2004 ; 19(5) : 1032-1036.
5. Japanese source
6. Yasuda G, Kuji T, Hasegawa K, Ogawa N, Shimura G, Ando D, Umehara S. Safety and efficacy of fluvastatin in hyperlipidemic patients with chronic renal disease. Renal Failure 2004 ; 4 : 411-418.
7. Buemi M, Allegra A, Corica F, Aloisi C, Giacobbe M, Pettinato G, Corsonello A, Senatore M, Frisina N. Effect of fluvastatin on proteinuria in patients with immunoglobulin A nephropathy. Clin Pharmacol Ther 2000 ; 67(4) : 427-431.
8. Therap Res 2002 ; 23(7) : 1324-1326.
9. Chan PCK, Robinson JD, Yeung WC, Cheng IKP, Yeung HWD, Tsang MTS. Lovastatin in glomerulonephritis patients with hyperlipidemia and heavy proteinuria. Nephrol Dial Transplant 1992 ; 7(2) : 93-99.
10. Fried LF, Orchard TJ, Kassiske BL. Effect of lipid reduction on the progression of renal disease : A metaanalysis. Kidney Int 2001 ; 59 : 260-269.
11. Stefano B, Roberto B, Alberto C, Vito MC. A controlled, prospective study of the effect atorvastatin on proteinuria and progression of kidney disease. Am J Kidney Dis 2003 ; 41 : 565-570.
12. Athyros VG, Mikhailidis DP, Papageorgiou AA, Symeonidis AN, Pehlivanidis AN, Bouloukos VI, Elisaf M. The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease. A subgroup analysis of Greek atorvastatin and coronary heart disease evaluation (GREACE) study. J Clin Pathol 2004 ; 57 : 728-734.
13. 1 receptor blockers. Kidney Int 2005 ; 68 : 779-787.